ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
As on 17 Apr 2025

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
EquityNAV
₹ 39.27
CAGR (3 Years)
23.01%
AUM (Cr)
₹ 4,914.64
Risk
Very High Risk
About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objective of the scheme would b
Breakdown of this Fund
Chemicals
12.74%
Debt Others
3.36%
Derivatives - Index
0.52%
Finance
0.79%
Healthcare
22.81%
Insurance
11.92%
Pharmaceuticals
152.25%
Retail
4.55%
Market Capitalization
Expense Ratio, Exit Load and Tax
Expense Ratio
1.83
Exit Load
1.00% - if units purchased or switched in from another Scheme of the Fund are re...
Stamp Duty
0.005% (from July 1st, 2020)
Tax Implication
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.